In December, the company postponed a planned IPO and announced a deal with Novartis to develop a synthetic ligand affinity adsorbent for the purification of a recombinant protein vaccine [See PM 12/07/06].
Bill Craumer, Paul Goulding, Bruce Pritchard, Peter Edwardson, Stephane Archambault, Mark Bandrauk, Patrick Sartore, Suzie Guillemette
Bill Craumer has become director of investor relations at Applied Biosystems. He was director of corporate marketing and communications at Illumina.
Nonlinear Dynamics this week appointed Paul Goulding as distributor manager. Goulding had been at UVltec. In his new position, he will focus initially on expanding Nonlinear’s distribution network in Asian Pacific and developing existing distribution partnerships.
The company also said it has signed on SCRUM, a scientific sales and marketing firm, as its distributor in Japan.
Synthetic protein manufacturer ProMetic Life Sciences this week announced the following changes to its management: Bruce Pritchard became vice president of corporate development. He remains CFO of the company’s UK subsidiary.
Peter Edwardson becomes VP medical technologies. He had been VP at PRDT. Stephane Archambault has been promoted to CFO for the ProMetic group. He had been acting VP of finance.
The company reorganized its legal department. The position of general counsel, which was held by Mark Bandrauk, has been eliminated. Patrick Sartore and Suzie Guillemette, both senior legal counsels, will take over all legal work for ProMetic. Sartore also has been nominated as corporate secretary.
In a press release, Pierre Laurin, ProMetic’s president and CEO, said that the changes are a “clear progression toward a corporate structure better suited to manage growth resulting from anticipated business transactions.”